Results 291 to 300 of about 326,443 (336)

Noninvasive Evaluation of HER2 Expression and Heterogeneity in Urothelial Carcinoma on 68Ga-HER2-affibody PET/CT. [PDF]

Clin Nucl Med
Tao Z, Chen X, Tang Q, Duan X, Yin L, Li H, Li X, Zhang J, Li X.   +8 more
europepmc   +1 more source

Global Disproportionality Analysis of Adverse Event Reports on Interstitial Lung Diseases for Cancer‐Targeted Therapies, 1968–2024

Respirology, EarlyView.
ABSTRACT Background and Objectives The increasing complexity of interstitial lung disease (ILD) related to cancer‐targeted monoclonal antibodies (mAbs) has emerged as a significant clinical concern. Thus, this study aimed to investigate reporting signals of four ILD subtypes detected with cancer‐targeted mAbs.
Jinyoung Jeong, Hyunjee Kim, Sooji Lee, Jiyoung Hwang, Lee Smith, Ho Geol Woo, Jaehyeong Cho, Dong Keon Yon   +7 more
wiley   +1 more source

A real-world study on clinical features and prognosis of Chinese breast cancer patients with brain metastases. [PDF]

Front Oncol
Chen HD, Liao XW, Chen XG, Su YN, Pan DL, Chen GZ, Wu M, Cai SL.   +7 more
europepmc   +1 more source

2D van der Waals System Integrated with Targeting Radio‐Diagnostic and Imaging Functions

Small, EarlyView.
Layered double hydroxide (LDH) nanoplates were engineered for tumor‐targeted imaging and therapy. By exploiting folate receptor (FR) expression levels, the system achieves selective tumor accumulation and high‐resolution dual PET/fluorescence (PET/FL) imaging.
Sairan Eom, Jae Hun Ahn, Jung Yung Kim, Kyo Chul Lee, Yong Jin Lee, Sanoj Rejinold N, Jin‐Ho Choy   +6 more
wiley   +1 more source

Maintenance therapy in hormone receptor-positive and human epidermal growth factor receptor 2-positive metastatic breast cancer: a real-world multicenter retrospective study. [PDF]

Front Oncol
Bao S, Chen J, Yin Y.
europepmc   +1 more source

Improving HER2 Diagnostics with Digital Real‐Time PCR for Ultrafast, Precise Prediction of Anti‐HER2 Therapy Response in Patients with Breast Cancer

Small Methods, EarlyView.
This study presents a novel, clinically feasible HER2 testing method using a fully automated digital real‐time PCR platform. It enables real‐time absolute quantification of ERBB2 copy number alterations for rapid, simple, and accurate assessment of HEgR2 status, thereby overcoming the limitations of conventional testing and improving prediction of anti‐
Hee‐Joo Choi, Soo Young Park, Minsik Song, Jinhyuk Chang, YoonSik Kim, Hosub Park, Chihwan David Cha, Sohyeon Yang, Nam Hun Heo, Min Ji Song, Da Sol Kim, Hayeon Kim, Minuk Kim, Jae Eun Park, Yesung Lee, EunChae Ji, Heekyoung Chung, Ilecheon Jeong, Mineui Hong, Jin‐Wu Nam, Mee‐Hye Oh, Ji‐Hye Lee, Jinwoo Seol, Hee‐Young Won, Hyun‐Woo Song, Jaewon Eom, Do Young Lee, Han Suk Ryu, Si‐Hyong Jang, Jeong‐Yeon Lee   +29 more
wiley   +1 more source

Inetetamab-Based Regimens for Patients with HER2-Positive Metastatic Breast Cancer: A Real-World Retrospective Study. [PDF]

Breast Cancer (Dove Med Press)
Chen L, Huang J, Chen X, Lan X, Song L, Xie X, Bai X, Du C.   +7 more
europepmc   +1 more source

Recent Advances in Bioconjugation of Aromatic Amino Acid Residues by a Reactivity‐Guided Approach

The Chemical Record, EarlyView.
This review highlights recent advances in the bioconjugation of aromatic amino acids residues, focusing on strategies that leverage their inherent chemical reactivity to enable precise and versatile modifications of biomacromolecules, illustrating relevant applications.
Bruno M. da S. Santos, Lívia C. R. M. da Frota, Thais G. Silva, Fernanda G. Finelli   +3 more
wiley   +1 more source

Hotspot mutations in HER2 interfaces destabilize structure, causing breast cancer treatment failure. [PDF]

Oncogene
Dey P, Bishnu A, Patel J, Mishra S, Gadewal N, Ray P, Gupta S, De A.   +7 more
europepmc   +1 more source

Pathological response to neoadjuvant chemotherapy and survival in patients with breast cancer: A multicentric retrospective study. [PDF]

Oncol Lett
Séka EN, Traoré DA, Saki CT, Traoré K, Tuo AG, Doukouré B.   +5 more
europepmc   +1 more source